Subscribe
0
  • Facebook Social Icon
  • LinkedIn Social Icon
  • Vimeo Social Icon
  • YouTube Social Icon

  • HOME

  • ABOUT

  • LIBRARY

  • MACD

  • WEALTH MANAGEMENT

  • PRESS

  • STORE

  • CLIENT RELATOINSHIP

  • CONTACT

  • More

    STORE > PRODUCT PAGE

     

    Book - Beating the Market

    $23.95Price

    • Beating the Market, 3 Months at a Time” offers well researched strategies designed to increase your investment returns by staying on the right side of major long-term market trends. A must read for investors, experienced or not.

       

      Gerald Appel is the chairman of Signalert Asset Management and the inventor of MACD. Dr. Marvin Appel is the president of Signalert and serves as the editor and contributor of Systems & Forecasts.

    • No refunds or returns

    • Continental US: FREE

      International: $20

    The Image below may not be a depiction of the actual product, used for Illustration purpose only.

    © 2012-2018 by Signalert Asset Management LLC.
     

    525 Northern Boulevard, Suite 210

    Great Neck, N.Y. 11021

    marketletter@signalert.com

    (516) 829-6444

    Subscribe
    • Facebook Social Icon
    • LinkedIn Social Icon
    • Vimeo Social Icon
    • YouTube Social Icon

    This material is not intended to be, nor should it be used as, financial, legal, tax or investment advice nor an opinion or recommendation by Signalert Asset Management LLC (“Signalert”) regarding the appropriateness of any investment. This material is as of the dates indicated, is not a complete description of Signalert’s services, and is subject to revision and updating. This material does not take into account the particular investment objectives or financial circumstances of any specific client or type of client. Signalert’s products may not be suitable for all clients. No representation or guarantee is made that a client is likely to achieve his or her investment objectives through investing with Signalert, or will be profitable or will not sustain a loss. Past performance is not indicative of future results. Any questions may be addressed to 844.829.6444. See Disclaimer and Privacy Policy. January 31, 2012, All Rights Reserved.